Procter & Gamble Health Ltd.
Snapshot View

4785.50 -131.60 ▼-2.7%

21 March 2023, 04:01:00 PM
Volume: 905

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.pghealthindia.com
Market Cap 8,057.92 Cr.
Enterprise Value(EV) 7,750.79 Cr. 2022-12
Financial Indicators
Earnings per share (EPS) 140.25 Trailing Twelve Months Ending 2022-12
Price-Earning Ratio (PE) 34.61 Trailing Twelve Months Ending 2022-12
Industry PE 31.71 Trailing Twelve Months Ending 2022-12
Book Value / Share 442.46 Trailing Twelve Months Ending 2022-12
Price to Book Value 10.97 Calculated using Price: 4,854.35
Dividend Yield 1.08 Period Ending 2022-06
No. of Shares Subscribed 1.66 Cr. 16,599,382 Shares
FaceValue 10
Company Profile
Till 2018, the Company was operating in all businesses included in the pharmaceuticals and chemicals businesses in the country. The company is one of India's largest VMS Companies manufacturing and marketing over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle and improved quality of life. Its trusted products are household names in India protecting and supporting millions of people at every stage of life.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-2.68%
1 Week
-1.93%
1 Month
+3.82%
3 Month
+15.62%
6 Month
+17.01%
1 Year
+10.23%
2 Year
-25.66%
5 Year
+218.08%
10 Year
+665.93%
9 years 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2020-06 2021-06 2022-06
Return on Equity (%) 11.10 8.02 9.35 12.61 8.74 8.95 20.79 22.04 29.41
Return on Capital Employed (%) 17.53 12.36 14.54 18.35 14.16 13.90 29.01 29.08 38.45
Return on Assets (%) 6.71 4.67 3.92 5.48 4.24 4.96 10.82 8.65 9.82

Balance Sheet View Details >>

Particulars 10 years 2013-12 Rs. Cr. 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2020-06 Rs. Cr. 2021-06 Rs. Cr. 2022-06 Rs. Cr. 2022-12* Rs. Cr.
Shh. Funds 523 554 592 664 733 1,540 906 704 616 734
Non Curr. Liab. 13 390 395 399 431 495 667 723 715 35
Curr. Liab. 112 260 539 301 352 548 539 551 612 288
Minority Int.
Equity & Liab. 648 1,204 1,525 1,363 1,516 2,583 2,112 1,978 1,943 1,058
Non Curr. Assets 171 581 579 613 637 693 847 939 954 279
Curr. Assets 478 623 946 750 879 1,889 1,265 1,039 989 779
Misc. Exp. not W/O
Total Assets 648 1,204 1,525 1,363 1,516 2,583 2,112 1,978 1,943 1,058

Profit Loss View Details >>

Particulars 10 years 2013-12 Rs. Cr. 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2020-06 Rs. Cr. 2021-06 Rs. Cr. 2022-06 Rs. Cr. 2022-12 Rs. Cr. TTM
Net Sales 798 867 940 993 698 849 1,356 1,009 1,114 1,171
Other Income 21 20 23 24 30 28 70 18 13 13
Total Income 819 888 963 1,017 729 877 1,426 1,027 1,128 1,185
Total Expenditure -721 -809 -856 -877 -628 -705 -1,042 -763 -847 -842
PBIDT 98 79 107 140 101 173 384 264 281 342
Interest -1 0 -1
Depreciation -10 -13 -23 -25 -19 -21 -29 -30 -27 -31
Taxation -32 -23 -30 -36 -38 -56 -101 -56 -61 -78
Exceptional Items 17 7
PAT 56 43 54 79 61 102 254 177 193 233
Adjusted EPS 34 26 32 48 37 61 153 107 116 140

Cash Flow View Details >>

Particulars 10 years 2012-12 Rs. Cr. 2013-12 Rs. Cr. 2014-12 Rs. Cr. 2015-12 Rs. Cr. 2016-12 Rs. Cr. 2017-12 Rs. Cr. 2018-12 Rs. Cr. 2020-06 Rs. Cr. 2021-06 Rs. Cr. 2022-06 Rs. Cr.
Cash Fr. Operatn. 54 0 5 83 107 54 -130 235 247 170
Cash Fr. Inv. -82 7 11 -68 -75 -48 1,270 165 -32 -26
Cash Fr. Finan. -5 -17 -12 -15 -22 -30 -883 -387 -289
Net Change -28 3 -1 4 17 -16 1,109 -483 -172 -145
Cash & Cash Eqvt 4 7 5 9 26 10 1,119 636 464 319

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 51.82 51.82 51.82 51.82 51.82 51.82 51.82 51.85 51.82
Public 48.18 48.18 48.18 48.18 48.18 48.18 48.18 48.15 48.18
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 17 Mar 2023
Announcement under Regulation 30 (LODR)-Change in Directorate
It is informed that pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Board of Directors of the Company at its meeting held today have appointed Ms. Seema Sambasivan as an Additional (Non-Executive) Director of the Company with effect April 1 2023 subject to allotment of Director Identification Number by the Ministry of Corporate Affairs. Ms. Sambasivan will hold office as Additional Director up to the ensuing Annual General Meeting.Brief Profile of Ms. Seema Sambasivan is enclosed.Kindly take the same on record and oblige.
Fri, 17 Mar 2023
Organization Announcement- Appointment Of Chief Financial Officer
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Board of Directors of the Company at its meeting held today have appointed Mr. Lokesh Chandak as Chief Financial Officer effective April 1 2023.A brief profile of Mr. Chandak is enclosed for your kind perusal.Kindly take the same on record and oblige.
Fri, 17 Mar 2023
Announcement under Regulation 30 (LODR)-Change in Directorate
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform you that the Board of Directors of the Company at its meeting held today have appointed Mr. Lokesh Chandak as Additional (Executive) Director of the Company effective April 1 2023. His appointment as Director is subject to allotment of Director Identification Number by the Ministry of Corporate Affairs.Mr. Chandak will hold office as Additional Director up to the ensuing Annual General Meeting.Appointment of Mr. Chandak as Executive Director is also subject to approval of the Shareholders of the Company.A brief profile of Mr. Chandak is enclosed for your kind perusal.

Technical Scans View Details >>

Mon, 20 Mar 2023
Opening at High Opening at High
Closing Above Previous High Closing Above Previous High
Close Within 52 Week High Zone Close Within 52 Week High Zone
Close Above Last Month High Close Above Last Month High
High Increase in 1 Month High Increase in 1 Month

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 230,636.07 956.20 -0.5%
Divi's Laboratories Ltd. 74,303.33 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. 73,967.90 4,419.30 -0.5%
Cipla Ltd. 70,000.14 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. 61,905.77 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. 51,514.78 1,518.00 -0.3%
Zydus Lifesciences Ltd. 48,165.73 477.95 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 54.76 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 31.06 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 20.25 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-12 26.53 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 80.95 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 61.90 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 23.34 477.95 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.17 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-12 5.98 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.35 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-12 3.08 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-12 10.04 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.07 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-12 2.79 477.95 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 0.04 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 477.95 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.93 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 13.10 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 477.95 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 477.95 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 956.20 -0.5%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,773.45 -0.9%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,182.50 4,419.30 -0.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 862.70 -0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,272.60 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,518.00 -0.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 477.95 +0.4%

FAQ's On Procter & Gamble Health Ltd.

What is Procter&Gamble Healt share price?

Can I buy Procter&Gamble Healt shares now?

What is the Dividend Yield of Procter&Gamble Healt?

What is the Market Cap of Procter&Gamble Healt?

What are the key metrics to analyse Procter&Gamble Healt?

What is the 52 Week High and Low of Procter&Gamble Healt?

What is the trend of Procter&Gamble Healt share price?